Stay updated on CC-220 in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the CC-220 in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CC-220 in Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The history adds a note that the trial is no longer looking for participants, signaling recruitment closure. The revision version has been updated from v3.5.5 to v3.6.0, indicating a new version of the study record.
    Difference
    0.2%
    Check dated 2026-06-13T05:23:13.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A new revision label v3.5.5 was added and the previous v3.5.4 label removed, reflecting a minor update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-06-05T22:45:41.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page shows an updated Revision: v3.5.4, replacing the previous v3.5.3, indicating a platform update with no apparent changes to study information.
    Difference
    0.0%
    Check dated 2026-05-15T14:57:01.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3. This reflects a site software release rather than a change to the underlying trial record content.
    Difference
    0.0%
    Check dated 2026-04-24T06:13:29.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added and v3.5.0 was removed in the record history. These are internal version updates and do not alter trial data or visible content.
    Difference
    0.0%
    Check dated 2026-04-17T02:33:27.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Changed the study title wording from 'Dose, Safety, Tolerability, Drug Levels, and Efficacy' to 'Dose, Safety, Tolerability and Efficacy'. Updated the status from 'Results Submitted' to 'Results Posted' and added new sections such as More Information, Limitations and Caveats, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and References in the 2026 version.
    Difference
    0.9%
    Check dated 2026-03-26T11:25:19.000Z thumbnail image

Stay in the know with updates to CC-220 in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CC-220 in Multiple Myeloma Clinical Trial page.